Description
P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
Article: P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
€2.42
Related products
-
Article: Calendar of events
€2.42 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in digestive oncology
€2.42 Add to cart -
Article: Highlights in melanoma
€2.42 Add to cart
